Genuine question - The announcement says that mean follow-up was 30 months. Other than completion (which I personally consider a step not an endpoint), this is the only other fact stated. Anyone care to interpret the significance (if any) of that? The presentations have previously said 17-45% globally die within 1 year of hospital admission (advanced and end stage) with majority of advanced heart failure patients die within 5 years.
- Forums
- ASX - By Stock
- MSB
- Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events
Ann: CHF P3 Trial Accrues Sufficient Primary Endpoint Events, page-10
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.19 |
Change
-0.068(5.38%) |
Mkt cap ! $1.367B |
Open | High | Low | Value | Volume |
$1.22 | $1.23 | $1.18 | $5.327M | 4.440M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 59882 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 61523 | 30 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 63940 | 1.185 |
24 | 371403 | 1.180 |
18 | 180641 | 1.175 |
19 | 194061 | 1.170 |
10 | 158241 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 55537 | 28 |
1.195 | 114037 | 18 |
1.200 | 116846 | 14 |
1.205 | 71624 | 8 |
1.210 | 58051 | 4 |
Last trade - 13.21pm 25/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |